Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted morpholine compounds for the treatment of central nervous system disorders

Substituted morpholine compounds for the treatment of central nervous system disorders

US Patent 7659394 · Granted Feb 9, 2010

Estimated economic value: $431,241,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Heteroaromatic compounds and their use as dopamine D1 ligands2024
Heteroaromatic compounds and their use as dopamine D1 ligands2021
Heteroaromatic compounds and their use as dopamine D1 ligands2020
Heteroaromatic compounds and their use as dopamine D1 ligands2019
Heteroaromatic compounds and their use as dopamine D1 ligands2018
Heteroaromatic compounds and their use as dopamine D1 ligands2018
Heteroaromatic compounds and their use as dopamine D1 ligands2018
Heteroaromatic compounds and their use as dopamine D1 ligands2018
Heteroaromatic compounds and their use as dopamine D1 ligands2017
Heteroaromatic compounds and their use as dopamine D1 ligands2017
Heterocyclic compounds and their use as dopamine D1 ligands2017
Triazine compounds and compositions thereof and methods for treating malaria and2017